Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07446608Recruiting

MRI-Based Prediction of Dienogest Response in Endometriosis

Role: lead

NCT05257824Phase 4Completed

Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

Role: collaborator

NCT04988503Not ApplicableTerminated

Bare Platinum Coils Versus Second-generation Hydrocoils

Role: collaborator

NCT07012733Not ApplicableNot Yet Recruiting

Thoracic Mobilization for Restrictive Lung Disease

Role: lead

NCT04811677Completed

Comparison of a SegNet-based Algorithm Estimating Epifascial Fibrosis

Role: lead

NCT05176613Not ApplicableCompleted

Effects of High Frequency rTMS Combined Motor Learning on Upper Limb Motor Function in Subacute Stroke

Role: lead

All 6 trials loaded